CompoAtlas

A-Trémorine (poudre) Viaphyt

Food supplement declared in France, declaration No 2018-2-495, decision dated 9 February 2018

A-Trémorine (poudre) Viaphyt is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
VIAPHYT B-V
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Poudre
Daily dose
10 grammes / j
Directions for use
5 grammes (1 mesurette) matin et soir soit 10 g / j.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous traitement médicamenteux, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Système nerveux, Concentration

Declaration 286373, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Vicia faba L.CosseAutre extrait sec9.967 g

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Mélange de tocophérolsVitamine E300 mg30 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Les populations femmes enceintes ou allaitantes et enfants doivent consulter leur médecin avant utilisation. De même pour les traitements à long terme (plus de trois mois). De même pour les personnes suivant un traitement médicamenteux. Déconseillé en cas de favisme.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line